International Journal Of Cancer

International Journal Of Cancer

国际癌症杂志

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《International Journal Of Cancer》是由Wiley-Liss Inc.出版社于1966年创办的英文国际期刊(ISSN: 0020-7136,E-ISSN: 1097-0215),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.2040...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比91.83%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在355篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

International Journal Of Cancer审稿周期约为 约1.5月 。该刊近年未被列入国际预警名单,年发文量约355篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • Multi-Language 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 355 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 54 / 322

83.4%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 60 / 322

81.52%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:13.4 SJR:2.131 SNIP:1.67
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 38 / 404

90%

大类:Medicine 小类:Cancer Research Q1 32 / 230

86%

期刊发文

  • Special issue The advance of solid tumor research in China: Participants with a family history of cancer have a higher participation rate in low-dose computed tomography for lung cancer screening

    Author: Guo, Lan-Wei; Meng, Qing-Cheng; Zheng, Li-Yang; Chen, Qiong; Liu, Yin; Xu, Hui-Fang; Kang, Rui-Hua; Zhang, Lu-Yao; Liu, Shu-Zheng; Sun, Xi-Bin; Zhang, Shao-Kai

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 1, pp. 7-14. DOI: 10.1002/ijc.34010

  • Special issue The advance of solid tumor research in China: Prognosis prediction for stage II colorectal cancer by fusing computed tomography radiomics and deep-learning features of primary lesions and peripheral lymph nodes

    Author: Li, Menglei; Gong, Jing; Bao, Yichao; Huang, Dan; Peng, Junjie; Tong, Tong

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 1, pp. 31-41. DOI: 10.1002/ijc.34053

  • Special issue The advance of solid tumor research in China: Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in China

    Author: Su, Chunxia; Zhou, Juan; Qiang, Huiping; Zhao, Jing; Chang, Qing; Ji, Xianxiu; Li, Jiaqi; Xie, Mengqing; Chu, Tianqing

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 1, pp. 15-23. DOI: 10.1002/ijc.34123

  • Special issue The advance of solid tumor research in China: Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response

    Author: Tian, Xi; Wang, Yue; Xu, Wenhao; Tang, Haidan; Zhu, Shuxuan; Anwaier, Aihetaimujiang; Liu, Wangrui; Wang, Wenfeng; Zhu, Wenkai; Su, Jiaqi; Qu, Yuanyuan; Zhang, Hailiang; Ye, Dingwei

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 1, pp. 66-78. DOI: 10.1002/ijc.34121

  • Special issue The advance of solid tumor research in China: Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy

    Author: Wang, Yueming; Huang, Jiwei; Zhang, Cuijian; Hu, Xiaoyi; Wang, Ping; Shi, Guohai; Zhang, Jin; Kong, Wen; Chen, Yonghui; Huang, Yiran; Ye, Dingwei; Xia, Dan; Guo, Jianming; He, Zhisong; Xue, Wei

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 1, pp. 24-30. DOI: 10.1002/ijc.34173

  • Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma

    Author: Xu, Biaoming; Chen, Yu; Peng, Mingjing; Zheng, Jin Hai; Zuo, Chaohui

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 2, pp. 110-122. DOI: 10.1002/ijc.34195

  • The survival of esophageal cancer by subtype in China with comparison to the United States

    Author: An, Lan; Zheng, Rongshou; Zeng, Hongmei; Zhang, Siwei; Chen, Ru; Wang, Shaoming; Sun, Kexin; Li, Li; Wei, Wenqiang; He, Jie

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 2, pp. 151-161. DOI: 10.1002/ijc.34232

  • Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine

    Author: Mui, Chun Wai; Chan, Wai Nok; Chen, Bonan; Cheung, Alvin Ho-Kwan; Yu, Jun; Lo, Kwok Wai; Ke, Huixing; Kang, Wei; To, Ka Fai

    Journal: INTERNATIONAL JOURNAL OF CANCER. 2023; Vol. 152, Issue 4, pp. 558-571. DOI: 10.1002/ijc.34249